Table 3 Kaplan–Meier survival estimate of risk of therapeutic failure of CQ for the treatment of P.vivax malaria cases in Guragea zone, southern central Ethiopia from December, 2016 - May, 2017
Follow up period | At Risk | Excluded from the study | Treatment failure | Survival Probability Estimate | Cumulative Hazard |
|---|---|---|---|---|---|
Day 0 | 87 | 0 | 0 | 1 | 0 |
Day 1 | 87 | 0 | 0 | 1 | 0 |
Day 2 | 87 | 1 | 0 | 1 | 0 |
Day 3 | 86 | 0 | 0 | 1 | 0 |
Day 7 | 86 | 3 | 0 | 1 | 0 |
Day 14 | 83 | 2 | 0 | 1 | 0 |
Day 21 | 81 | 0 | 1 | 0.99 | 0.01 |
Day 28 | 79 | 0 | 1 | 0.96 | 0.04 |
Total | 6 | 2 |